Incidence of Patellar Crepitus in Removal and Non-removal of Fibrosynovial Tissue at Superior Pole of Patella
NCT ID: NCT04429997
Last Updated: 2021-08-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
138 participants
INTERVENTIONAL
2020-06-10
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Different Size of Patellar Resurfacing on Patellar Crepitus of the One-stage Bilateral Total Knee Arthroplasty.
NCT06811506
Partial Synovectomy in Articular Side of Quadriceps Tendon Verified to Reduce Crepitus in Retrospective Study
NCT06129214
Total Fat Pad Excision Leads to Worse Isokinetic Performance in Total Knee Arthroplasty
NCT04419142
Comparison of Post-operative Knee Range of Motion and Functions Between Intraoperative Complete and Incomplete Patellofemoral Articular Contacts in Patients Undergoing Total Knee Arthroplasty
NCT05349461
The Comparison of Anterior Knee Pain in Patella With or Without Denervation in Medial Unicompartmental Knee Arthroplasty
NCT03676179
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Removal of fibrosynovial tissue
Removal of fibrosynovial tissue in patellar non-resurfacing TKA
Removal of fibrosynovial tissue
Remove of fibrosynovial tissue at the superior border of patella
Non-removal of fibrosynovial tissue
Non-removal of fibrosynovial tissue in patellar non-resurfacing TKA
Non-removal of fibrosynovial tissue
Do not remove of fibrosynovial tissue at the superior border of patella
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Removal of fibrosynovial tissue
Remove of fibrosynovial tissue at the superior border of patella
Non-removal of fibrosynovial tissue
Do not remove of fibrosynovial tissue at the superior border of patella
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* History of inflammatory arthroplathy
* Previous fracture or open surgery on the same knee
* History of patellar instability
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Navamindradhiraj University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Satit Thiengwittayaporn
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Satit Thiengwittayaporn, M.D.
Role: PRINCIPAL_INVESTIGATOR
Department of Orthopaedics, Faculty of Medicine Vajira Hospital, Navamindradhiraj University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Navamindradhiraj University
Dusit, Bangkok, Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COA 057/2563
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.